AI creates new legal challenges in the field of patentability
“Artificial intelligence” (AI) is used to extract and restructure information from raw or unstructured data. Companies are using it to identify phenotypic traits associated with genetic sequences. Referring to a recent patent application by the company Inari, the German NGO Testbiotech points out the risks associated with the combination of new genomic modification techniques (NGT) and AI. It condemns the possible abuses of patentability and the need for robust GMO regulations. However, Inari has already filed other similar applications, which raises questions about the legal impact of such rights and their adaptation to AI-driven technologies.
“Artificial intelligence” to digitize genomes
The digitization of living organisms is the subject of a growing number of projects. Computer data, generated and stored in ever-larger “data centers”, are used by “artificial intelligence” matrices. These data are of all kinds: genetic sequences, proteins, etc. In these fields, which require increasing natural resources, investments are multiplying.